Cambridge Healthtech Institute’s Fifth Annual
Optimizing Protein Expression
Enhancing Expression Systems
Part of the 11th Annual PEGS: the essential protein engineering summit
May 6-7, 2015 | World Trade Center | Boston, Massachusetts


When expressing protein, there are a variety of expression systems to choose from. CHO is seen as the ‘king’ in the industry, but does it meet all needs of rapid production and budget constraints? This meeting will explore “Optimizing Protein Expression” through understanding and enhancing expression systems, and will especially focus on CHO cells, and other mammalian systems, E.coli and yeasts. Other host systems, such as baculovirus and algae, will be touched on as well. Along with case studies, the meeting will feature experts who reveal the underlying mechanisms and insights into the varying systems in order to enhance protein expression. Comparing and contrasting systems will also be featured to provide greater understanding of how these systems function within the context of the results achieved.

Learn the latest protocols and see how protein science leaders are enhancing expression systems to reach greater productivity.

Topics may include, but are not limited to: 

  • Expression systems:
    • CHO cells
    • Escherichia coli
    • Saccharomyces cerevisiae
    • Pichia pastoris
    • Baculovirus
    • Algae
    • HEK
    • NSO
  • Mechanisms/properties of different expression systems
  • Compare/contrast different systems
  • Recombinant proteins
  • Tags
  • Genetic engineering technologies
  • Process & Product Development
  • Fast & efficient production
  • Expression conditions
  • High throughput
  • Quality & Productivity
  • Case Studies

Protein Expression Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

The deadline for submission is October 3, 2014 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Mary Ruberry
Conference Director
Cambridge Healthtech Institute
T: 781-972-5421
E: mruberry@healthtech.com 

For partnering and sponsorship information, please contact:
Jason Gerardi (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452
E: jgerardi@healthtech.com 

Carol Dinerstein (Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471
E: dinerstein@healthtech.com